Figure 4From: Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patientsGlobal ratings of efficacy and tolerability by physicians and patients during course 1. A) Efficacy, physician. B) Tolerability, physician. C) Efficacy, patient. D) Tolerability, patient.Back to article page